154 related articles for article (PubMed ID: 15730218)
1. [Indication for the treatment of Helicobacter pylori infection].
Svestka T; Krechler T; Brůha R; Jablonská M
Cas Lek Cesk; 2004; 143(12):850-3. PubMed ID: 15730218
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Helicobacter pylori infections in gastric and duodenal ulcers].
Svestka T
Cas Lek Cesk; 2003 Aug; 142(8):483-6. PubMed ID: 14626564
[TBL] [Abstract][Full Text] [Related]
3. How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians.
Breuer T; Goodman KJ; Malaty HM; Sudhop T; Graham DY
Am J Gastroenterol; 1998 Apr; 93(4):553-61. PubMed ID: 9576447
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Helicobacter pylori infection in patients with peptic ulcer disease.
Godshall CJ
Am J Surg; 2002 Jan; 183(1):2-3. PubMed ID: 11869692
[TBL] [Abstract][Full Text] [Related]
5. [Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens].
Cheng H; Hu FL; Li J
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2679-82. PubMed ID: 17199976
[TBL] [Abstract][Full Text] [Related]
6. [The evoluation of the strategy and tactics of treatment of Helicobacter pylori-dependent diseases].
Tsimmerman IaS
Klin Med (Mosk); 2007; 85(8):9-14. PubMed ID: 17926482
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori and non-malignant diseases.
Shirin H; Leja M; Niv Y
Helicobacter; 2008 Oct; 13 Suppl 1():23-7. PubMed ID: 18783518
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori.
Zaidi SF; Yamada K; Kadowaki M; Usmanghani K; Sugiyama T
J Ethnopharmacol; 2009 Jan; 121(2):286-91. PubMed ID: 19041711
[TBL] [Abstract][Full Text] [Related]
9. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
10. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori and non-malignant diseases.
Furuta T; Delchier JC
Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
[TBL] [Abstract][Full Text] [Related]
12. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
14. A better cure rate with 800 mg than with 400 mg clarithromycin regimens in one-week triple therapy for Helicobacter pylori infection in cigarette-smoking peptic ulcer patients.
Ishioka H; Mizuno M; Take S; Ishiki K; Nagahara Y; Yoshida T; Okada H; Yokota K; Oguma K
Digestion; 2007; 75(2-3):63-8. PubMed ID: 17476101
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS
Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
[TBL] [Abstract][Full Text] [Related]
16. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
17. [Current epidemiological and clinical issues regarding Helicobacter pylori infection in childhood].
Sýkora J; Pazdiora P; Varvarovská J; Pomahacová R; Stozický F; Siala K
Epidemiol Mikrobiol Imunol; 2006 Feb; 55(1):3-16. PubMed ID: 16528894
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and non-malignant diseases.
Rokkas T; Simsek I; Ladas S
Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
[TBL] [Abstract][Full Text] [Related]
19. Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
Kubben FJ; Sier CF; Schram MT; Witte AM; Veenendaal RA; van Duijn W; Verheijen JH; Hanemaaijer R; Lamers CB; Verspaget HW
Helicobacter; 2007 Oct; 12(5):498-504. PubMed ID: 17760717
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.
Kadayifci A; Buyukhatipoglu H; Cemil Savas M; Simsek I
Clin Ther; 2006 Nov; 28(11):1960-6. PubMed ID: 17213016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
